EEIC Fund
The EIC Fund is the venture arm of the European Innovation Council. It is a Luxembourg-based investment fund set up under private law in 2020, with the European Commission as its shareholder. It makes direct equity and quasi-equity investments in high-risk deep tech start-ups and SMEs across Europe, in all sectors. Tickets run from €0.5–10M under the EIC Accelerator and €10–30M under EIC STEP Scale Up, and the fund is run by an external fund manager, Alter Domus. It has invested more than €1 billion and brought in over €2.6 billion of co-investment, with holdings including the quantum computing companies PASQAL and IQM.
SectorsDeep tech, Quantum, Health & life sciences, Energy & climate, Space, Semiconductors, Advanced materials
VC MapPublic & regional funds
Team
S
Svetoslava Georgieva
Chair of the EIC Fund Board
P
Philippe Salpetier
Board Member (Director, Sales & Relationship Management)
L
Laurie-Anne Takerkart
Board Member (Company Secretary – Senior Manager, Legal Specialist Lead)
H
Hermann Hauser
Board Member (Co-founder of Amadeus Capital Partners)
Also at Amadeus Capital Partners →
H
Helen McBreen
Board Member (Partner at Atlantic Bridge)
Portfolio companies 40
Open 38 as list → On map →H
HAWK Biosystems
entered at Series A (estimated), 2026
XX1 Wind
entered at a round, 2022
VVaxdyn
entered at Series A, 2026
MMOA Foodtech
entered at Series A (estimated), 2026
IiPronics
entered at Series B, 2026
MMultiverse Computing
entered at Series A, 2024
HH2SITE
entered at Series B, 2026
PPeptomyc
entered at Series A (estimated), 2026
LLuxQuanta
entered at Series A, 2025
AARTHEx Biotech
entered at Series B, 2023
IIntegra Therapeutics
entered at Pre-Series A, 2025
MMYSPHERA
led a round, 2025
AAortyx
entered at Series A, 2025
AAlcyon Photonics
entered at Seed (estimated), 2025
WWooptix
entered at Series B, 2023
IINBRAIN Neuroelectronics
entered at Series B, 2024
A
Ability Pharmaceuticals
entered at Series A (estimated), 2024
AAEInnova
led Series A (estimated), 2021
IIgnion
entered at a round, 2023
MMethinks AI
led Seed (estimated), 2023
AADmit Therapeutics
entered at Series A (estimated), 2023
Bbound4blue
entered at Series A, 2023
CCARTO
entered at Series C, 2021
AAbora Solar
per company site
AAmadix
per company site
BBenviro
per company site
CCatalyxx
per company site
EELEM Biotech
per company site
GGenomcore
per company site
HHEMAV
per company site
IIdoven
KKanara
per company site
KKD
per company site
KKiin
per company site
MMiWEndo Solutions
per company site
PPalobiofarma
per company site
SSAALG Geomechanics
WWater Challenge
per company site
Exited or sunsetted (2)
SSmart Sensor Technology
per company site
S
Spectrapply
per company site